positive ninhydrin and RYDON-SMITH reactions. Sporaricins C and D show [a]v3 +126-and +125", respectively. Molecular formulae of C,BHU,N,OO (m/z 432) and C,SH3,N,O, (ml--417) for sporaricins C and D, respectively, were calculated from mass spectrometric and microanalytical data. In their IR spectra, absorption of an amide function was observed at 1625 and 1650 (sh) cm-' in sporaricin C ( Fig. 1) and at 1630 and 1665 cm-' in sporaricin D (Fig. 2) . Their 'H NMR spectra showed the presence of one anomeric proton, three methyl groups assigned to C-CH3, N-CH3 and O-CH3 and three methylene groups assigned to C-CH2-C, respectively (Table 3 ). In the spectrum of sporaricin D,
but not sporaricin C, a one proton singlet was observed at 8.71 ppm attributable to the N-formyl hydrogen of the former. From these properties sporaricins C and D are considered to be new aminoglycoside antibiotics.
Biological Properties
The antibacterial spectra of sporaricins C and D compared with sporaricin A are shown in Table 2 .
The antibacterial activity of sporaricins C and D are less active than that of sporaricin A.
Intravenous acute LD,, of both sporaricins C and D in mice were 200-300 mg/kg.
Structures of Sporaricins C and D
The molecular formulae C,BH36NB06 and C,,H35N,5O, were established for sporaricins C and D
(1 and 2) by FD and El mass spectra and elementary analysis, respectively. From their 1H NMR spectra, which were very similar to that of sporaricin A including the chemical shift of the N-CH; singlet, both 1 and 2 were presumed to be 4-N-acylsporaricins B. However, the methylene proton signal of the glycyl group which was observed at 5) 4.01 ppm in sporaricin A, was present at lower field (d 4.55 and 4.71 ppm in 1 and 2, respectively (Table 3) ). Moreover, an unprecedented signal at 6 8.71 ppm (1H, singlet) was observed only in the spectrum of 2.
Acetylation of 1 and 2 with acetic anhydride in methanol gave tri-N-acetyl compounds of I and 2, respectively. Alkaline hydrolysis of 1 with 1 N Ba(OH)2 at 100°C for 1 hour gave sporaricin B and hydantoic acid. Similar alkaline hydrolysis of 2 gave sporaricin B and glycine. When the free base of 2 in water was heated at 100°C for I hour, sporaricin B and formylglycine were detected.
From the results mentioned above, the structures of I and 2 were suggested to be 4-N-carbamoylglycyl-and 4-N-formylglycylsporaricin B, respectively.
In order to prove the structures of 1 and 2, 4-NV-carbamoylglycyland 4-N-formylglycylsporaricin B were synthesized. Sporaricin B was treated with N-(benzyloxycarbonyloxy)succinimide in the presence Catalytic hydrogenation of 6 and 7 gave 4-N-carbamoylglycyl-and 4-N-formylglycylsporaricin B in overall yields of 50% and 55%, respectively. These 4-N-substituted sporaricin B were identical with natural sporaricins C and D in specific rotation, IR and 'H NMR spectra and biological properties.
Experimental
The spectrometric data were obtained by the following instruments. Optical rotation; digital polarimeter DIP-4 of Japan Spectroscopic Co., Ltd., infrared spectra; Model DS-403G of Japan Spectroscopic Co., Ltd., mass spectra; Model JMS-01SG (FD) of Japan Electron Optics Lab. and Model RMU-6MG of Hitachi, 'H NMR spectra; Model JNM-MH-100 of Japan Electron Optics Lab. and 11C NMR spectra; Model JNM-FX -100 of Japan Electron Optics Lab . The chromatography were performed with the following reagents. Silica gel; Wako gel C-200 for column chromatography, E. Merck Kieselgel PF,,, nach Stahl for preparative thin-layer chromatography and E. Merck Kieselgel DC-Alufolien 60 F_ for thin-laver chromatoeranhv.
Isolation of Sporaricins C and D (1 and 2)
The sporaricin complex') (8.0 g) was adsorbed on a column of Amberlite CG-50 (NH,' form, 3 x 150 cm) and eluted by gradient elution between 0.05 N NH,OH (5 liters) and 0.5 N NH,OH (5 liters), and the eluate was cut into 25-ml fractions. Fractions were monitored by biological activity using a standard disc assay against Bacillus subtilis ATCC 6633 and were detected by ascending paper chromatography developed with a lower phase of CHCI, -MeOH -17% NH,OH (2: 1: 1). After elution Anal. Calcd. for C24H.,1N5O0,1H2O: C, 50.51; 7.77; N, 12.27. Found: C, 50.66; H, 7.28; N, 12.07. Alkaline Hydrolysis of 1 1 (2 mg) was dissolved in I N aqueous barium hydroxide (0.2 ml) and the solution was heated in a sealed tube at 100°C for 1 hour. The hydrolyzate was neutralized with carbon dioxide. On thinlayer chromatogram with CHCI, -MeOH -CH,COOH (10: 5: 1), the reaction mixture showed a spot at Rf 0.32 concurrent with hydantoic acid.
Sporaricin B was detected with the solvent systems reported previously').
Hydrolysis of 2 i) 2 (2 rig) was hydrolyzed in a similar manner as described for alkaline hydrolysis of 1 and the reaction was monitored by TLC examination. On TLC with CHCI, -MeOH -17 % NH,OH
(1: 8: 2), the reaction mixture gave two spots of sporaricin B (Rf 0.32) and glycine (Rf 0.57).
ii) A solution of free base of 2 (2 mg) in water (0.2 ml) was heated in a sealed tube at 100°C for 1 hour. On TLC with CHC1, -MeOH -CH,COOH (10: 5: 1), the reaction mixture gave a spot at Rf 0.47 concurrent with formylglycine. Sporaricins B and D, and glycine were also observed on TLC with CHCI;; -MeOH -17 NH4OH (1: 8: 2).
1,2',6'-Tris-N-benzyloxycarbonylsporaricin B
To a solution of sporaricin B (205 mg) in methanol (6 ml), nickel (II) acetate tetrahydrate (450 rig) was added, and the reaction mixture was stirred at room temperature for 30 minutes to give a clear greenish solution.
N-(Benzyloxycarbonyloxy)succinimide (514 mg) was added and the solution was stirred at room temperature for 2 hours.
After addition of concentrated ammonium hydroxide (6 nil), 1,2',6'-_Tris-N-benzyloxycarbonyl-4-N-(N-carbamoylglycyl)sporaricin_B (6) To a solution of hydantoic acid (118 mg) and N-hydroxysuccinimide (115 mg) in dimethylformamide (2 ml), dicyclohexylcarbodiimide (206 mg) was added and the mixture was stirred at room temperature for 2 hours. The resulting colorless crystal was filtered off and the filtrate was concentrated to give a syrup which was dissolved in a solution of tris-N-benzyloxycarbonylsporaricin B (5, 240 mg) and triethylamine (0.5 ml) in dioxane (7.5 ml), and the solution was heated at 70°C for 3 hours. The reaction mixture was concentrated to give a syrup which was dissolved in chloroform and washed with water, dried with Na,SO, and concentrated to give a syrup. The syrup was purified with preparative TLC (CHCI;, -MeOH, 10: 1) to give 6 as a colorless syrup, 207 mg (73 %); [a]24 --47° (c 2, CHCI3); 'H NMR (CDCI ,) 3: 1.09 (3H, CCH,), 3.30 (3H, s, OCH,).
1,2',6'-Tris-N-benzyloxycarbonyl-4-N-(N-formylglycyl)sporaricin B (7) Tris-N-benzyloxycarbonylsporaricin B (5, 300 mg) was treated with N-hydroxysuccinimide ester of formylglycine in a similar procedure as described for the preparation of 6 to give 7, 319 mg (95'/,);
[a]D21 -41° (c 2, CHCI3); 'H NMR (CDCI,) 6: 1.08 (3H, d, J-6 Hz, CCH,), 2.97 (3H, s, NCH,), 3.34 (3H, s, OCH3).
4-N-(N-Carbamoylglycyl)sporaricin B (1, Sporaricin C)
A solution of 6 (205 mg) in acetic acid (3 nil) was hydrogenated with 10% palladium on carbon under an atmospheric pressure of hydrogen.
After filtration, the filtrate was concentrated to about 1 ml. The concentrate was diluted with 200 ml of water and neutralized with aqueous ammonia.
The solution was charged on a column of CM-Sephadex C-25 (NH,+ form) and eluted with a linear gradient elution between 0.05 N NH,OH (100 ml) and 0.5 N NH,OH (100 nil). The eluate containing I was lyophilized to give a colorless solid of 1, 93 mg (77°!); fall,' -F126° (c 1, H~O).
4-N-(N-Formylglycyl)sporaricin B (2, Sporaricin D)
A solution of 7 (314 mg) in acetic acid (5 ml) was hydrogenated with 10% palladium on carbon. Purification in a similar manner as described for preparation of I gave 2 as a colorless solid, 115 mg (64,%%); [a"4 -= 127-'(c 1, MO).
